A Phase 2 Study of Palbociclib for Recurrent or Refractory Advanced Thymic Epithelial Tumors (KCSG LU17-21).
J Thorac Oncol
; 18(2): 223-231, 2023 Feb.
Article
in En
| MEDLINE
| ID: mdl-36307042
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Thymoma
/
Thymus Neoplasms
/
Neoplasms, Glandular and Epithelial
/
Lung Neoplasms
/
Neutropenia
Type of study:
Clinical_trials
Limits:
Humans
Language:
En
Journal:
J Thorac Oncol
Year:
2023
Document type:
Article
Country of publication:
United States